PR Newswire: news distribution, targeting and monitoring

Alliance for Regenerative Medicine Announces Agenda for Regen Med Investor Day

- Taking place April 17, 2013 in New York City; Agenda includes keynote talks, focused disease sessions with KOL participation and presentations from 16 top regenerative medicine companies -

Share with Twitter Share with LinkedIn

WASHINGTON, March 12, 2013 /PRNewswire/ -- The Alliance for Regenerative Medicine (ARM) today announced the agenda for its Regen Med Investor Day, the first investor event organized specifically for the regenerative medicine sector. The event will take place on April 17 at the Harmonie Club, 4 East 60th Street, New York, NY.

This one-day, high-impact program will provide institutional investors and life science analysts with insight from the industry's leading small- and mid-cap companies as well as exclusive access to regenerative medicine's top stakeholders.

Credentialed investors, life science strategic partners and members of the media should contact Laura Parsons at if interested in attending.


Breakfast & Networking


Welcome Remarks


Keynote Talk - Kieran Murphy, VP, President & CEO, GE Healthcare Life Sciences


Keynote Talk - Jeff Jonas, President, Shire Regenerative Medicine


Program Introduction - Jason Kolbert, Senior Biotechnology Analyst, Maxim Group


Clinical Outlooks in Cardiovascular Disease

Jason Kolbert, Senior Biotechnology Analyst, Maxim Group (moderator)

Douglas Losordo, MD, Adjunct Professor in Medicine-Cardiology, Northwestern University

Eduardo Marban, MD, Director, Cedars-Sinai Heart Institute

Leslie Miller, MD, Chair, College Of Medicine Dean's Office, University of South Florida




Regenerative Medicine in Wound Healing & Tissue Engineering

Ted Tenthoff, Managing Director & Senior Biotechnology Analyst, Piper Jaffray (moderator)

Vincent Falanga, MD, Professor, Boston University School of Medicine

Will Li, MD, President & Medical Director, The Angiogenesis Foundation

Thomas Serena, MD, FACS, CEO and Medical Director SerenaGroup


Therapeutics for a Broad Range of CNS Diseases

Ren Benjamin, Ph.D., Managing Director & Senior Biotechnology Analyst, Burrill & Company (moderator)

Sean Savitz, MD, Professor of Neurology, University of Texas Medical School, UTHealth


Plated Lunch & Networking


Lunchtime Presentation - G. Steven Burrill, CEO, Burrill & Company


Cytori Therapeutics - Chris Calhoun, CEO


Athersys - Gil Van Bokkelen, Chairman & CEO


Mesoblast - Silviu Itescu, CEO & President


Juventas Therapeutics - Rahul Aras, President & CEO


Aastrom Biosciences - Dan Orlando, Chief Commercial Officer


NeoStem - Robin Smith, Chairman & CEO


Pluristem Therapeutics - Zami Aberman, Chairman & CEO


Cytomedix - Martin Rosendale, CEO


Afternoon Break


Sangamo BioSciences - Edward Lanphier, President & CEO


BioTime Acquisition Corp - Thomas Okarma, President & CEO 


Advanced Cell Technology (ACT) - Gary Rabin, Chairman & CEO


StemCells Inc. - Martin McGlynn, President & CEO


Organogenesis - Geoff MacKay, President & CEO


Organovo - Keith Murphy, CEO


Tigenix - Eduardo Bravo, CEO


Mimedx - Michael Senken, CFO


Program Wrap-up - Ted Tenthoff, Managing Director & Senior Biotechnology

Analyst, Piper Jaffray


Networking Reception

This meeting is co-hosted by leading financial firms Burrill & Company, Piper Jaffray and Maxim Group and in partnership with Life Science Advisors and Blaise Group International.

The Alliance for Regenerative Medicine (ARM) is a Washington, DC-based non-profit organization that promotes legislative, regulatory, reimbursement, and financing initiatives necessary to facilitate access to life-giving advances in regenerative medicine. ARM also works to increase public understanding of the field and its potential to transform human healthcare, and provides services to support the growth of its member companies and organizations. Prior to the formation of ARM, there was no advocacy organization operating in Washington, DC to specifically represent the interests of regenerative medicine companies, research institutions, investors, and patient groups supporting more rapid adoption of technologies in our field. To learn more about ARM or to become a member, visit

Media Contact:
Michelle Linn
Linnden Communications
Phone: 508-362-3087

SOURCE Alliance for Regenerative Medicine


Featured Video

Journalists and Bloggers

Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.

View and download archived video content distributed by MultiVu on The Digital Center.

Share with Twitter Share with LinkedIn

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.



PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.


Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.


Online Member Center

Not a Member?
Click Here to Join
Search News Releases
Advanced Search
  1. PR Newswire Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
  5. Send a News Release